Form F-10 - Registration Statement for Securities of certain Canadian Issuers.:
SEC Accession No. 0001104659-22-069752
Filing Date
2022-06-10
Accepted
2022-06-09 17:47:44
Documents
8

Document Format Files

Seq Description Document Type Size
1 FORM F-10 tm2218106d1_f10.htm F-10 198710
2 EXHIBIT 5.1 tm2218106d1_ex5-1.htm EX-5.1 4358
3 EX-FILING FEES tm2218106d1_ex-filingfees.htm EX-FILING FEES 28661
4 GRAPHIC tm2218106d1_f10img001.jpg GRAPHIC 9038
5 GRAPHIC tm2218106d1_f10img02.jpg GRAPHIC 18346
6 GRAPHIC image_001.jpg GRAPHIC 1128
7 GRAPHIC image_002.jpg GRAPHIC 1259
8 GRAPHIC image_003.jpg GRAPHIC 1300
  Complete submission text file 0001104659-22-069752.txt   276175
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: F-10 | Act: 33 | File No.: 333-265510 | Film No.: 221007060
SIC: 2834 Pharmaceutical Preparations